ASTRAZENECA PHARMA INDIA LTD.
BSE: 506820
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 682.79+18.0% | 578.61-5.4% | 611.57+9.4% | 559.09+6.2% | 526.31+9.5% | 480.48+9.1% | 440.29+7.9% | 408.00 |
| Other Income | 9.23+55.1% | 5.95+16.0% | 5.13-16.9% | 6.17-45.1% | 11.24-30.4% | 16.15+102.3% | 7.98-2.1% | 8.15 |
| Total Income | 692.02+18.4% | 584.56-5.2% | 616.70+9.1% | 565.26+5.2% | 537.55+8.2% | 496.63+10.8% | 448.27+7.7% | 416.15 |
| EXPENSES | ||||||||
| Expenditure | 641.03+22.0% | 525.34-8.1% | 571.64+17.3% | 487.15+5.3% | 462.49+12.1% | 412.48+10.7% | 372.70+2.1% | 365.12 |
| Tax | 12.82-3.3% | 13.26-4.9% | 13.95-25.0% | 18.60-1.4% | 18.87-6.7% | 20.22+81.1% | 11.17-11.4% | 12.60 |
| PROFIT | ||||||||
| PBT | 50.75-12.7% | 58.14+24.9% | 46.54-36.1% | 72.82-2.5% | 74.70-4.8% | 78.47+86.7% | 42.02-17.7% | 51.03 |
| Net Profit | 37.93-15.5% | 44.88+37.7% | 32.59-39.9% | 54.22-2.9% | 55.83-4.2% | 58.25+88.8% | 30.85-19.7% | 38.43 |
| KEY METRICS | ||||||||
| OPM % | 7.13%-3.21pp | 10.34%+2.77pp | 7.57%-4.93pp | 12.50%-2.84pp | 15.34%-1.45pp | 16.79%+11.19pp | 5.60%-2.54pp | 8.14% |
| NPM % | 5.48%-2.20pp | 7.68%+2.40pp | 5.28%-4.31pp | 9.59%-0.80pp | 10.39%-1.34pp | 11.73%+4.85pp | 6.88%-2.35pp | 9.23% |
| EPS | 15.17-15.5% | 17.95+37.7% | 13.04-39.9% | 21.69-2.9% | 22.33-4.2% | 23.30+88.8% | 12.34-19.7% | 15.37 |
Corporate Events
Board MeetingASTRAZEN
202610Aug
Board Meeting
The 47th Annual General Meeting of the Company will be held …
BSE Filing ↗ Board MeetingASTRAZEN
202626May
Board Meeting
To consider and approve the audited financial results for th…
BSE Filing ↗ Board MeetingASTRAZEN
202413Nov
Board Meeting
Consider and approve the Unaudited Financial Results
BSE Filing ↗ Board MeetingASTRAZEN
20248Aug
Board Meeting
Consider and approve the Unaudited Financial Results
BSE Filing ↗ Board MeetingASTRAZEN
202427May
Board Meeting
To consider and approve the Audited financial results of the…
BSE Filing ↗ Board MeetingASTRAZEN
20248Feb
Board Meeting
Consider and approve Unaudited Financial Results for the qua…
BSE Filing ↗ Board MeetingASTRAZEN
20239Nov
Board Meeting
Consider and approve Unaudited Financial Results for the qua…
BSE Filing ↗ Board MeetingASTRAZEN
202314Aug
Board Meeting
Consider and approve the Unaudited Financial Results for the…
BSE Filing ↗